ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

VOR Vor Biopharma Inc

1.15
-0.05 (-4.17%)
14 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Vor Biopharma Inc VOR NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.05 -4.17% 1.15 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.22 1.11 1.22 1.15 1.20
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
10/6/202415:05EDGAR2Form 8-K - Current report
04/6/202415:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
28/5/202415:54EDGAR2Form 8-K - Current report
09/5/202415:05GLOBEVor Bio Reports First Quarter 2024 Financial Results and..
09/5/202415:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202407:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
03/5/202415:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
02/5/202415:01GLOBEVor Bio Appoints Accomplished Oncology and Cancer..
01/4/202407:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
20/3/202415:05GLOBEVor Bio Reports Fourth Quarter and Full Year 2023 Financial..
05/3/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
04/3/202407:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
14/2/202415:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202416:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202407:00GLOBEVor Bio to Participate in the Oppenheimer 34th Annual..
02/2/202415:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
31/1/202418:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202418:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202415:01GLOBEVor Bio Doses First AML Patient with VCAR33 (ALLO) and..
05/1/202416:03EDGAR2Form 8-K - Current report
21/12/202315:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
01/12/202315:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
27/11/202307:00GLOBEVor Bio to Participate in the JMP Securities Hematology and..
09/11/202315:01GLOBEVor Bio Presents Positive Data Update on Trem-cel at HSCT²..
08/11/202315:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202315:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202315:05GLOBEVor Bio Reports Third Quarter 2023 Financial Results and..
07/11/202315:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202315:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
03/11/202307:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
02/11/202308:10EDGAR2Form 8-K - Current report
02/11/202308:01GLOBEMultiple Clinical and Preclinical Presentations at ASH..
03/10/202315:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
25/9/202307:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
06/9/202315:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202315:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202315:51EDGAR2Form S-8 - Securities to be offered to employees in employee..
30/8/202307:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
10/8/202315:05GLOBEVor Bio Reports Second Quarter 2023 Financial Results and..
10/8/202315:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202315:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202315:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202307:00GLOBEVor Bio to Participate in the Wedbush PacGrow Healthcare..

Su Consulta Reciente

Delayed Upgrade Clock